| Not Yet Recruiting | Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers NCT06958224 | University Hospital, Lille | N/A |
| Not Yet Recruiting | 3D Liver Volumetry NCT07297615 | Medical University of Graz | N/A |
| Recruiting | Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection NCT07295275 | West China Hospital | — |
| Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064 | Imperial College London | — |
| Not Yet Recruiting | Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer NCT07226063 | Amit Mahipal | Phase 2 |
| Not Yet Recruiting | SL-28 for Advanced Solid Tumours NCT07341737 | Second Life Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | REGULUS: MRI-guided Adaptive SABR for Liver Cancers NCT07223307 | Stanford University | Phase 2 |
| Recruiting | Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection NCT07295340 | West China Hospital | — |
| Recruiting | Large Language Models Assist in Tumor MDT NCT07504367 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | N/A |
| Recruiting | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial NCT07447050 | University of California, Irvine | Phase 2 |
| Recruiting | Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer NCT07325565 | Tongji Hospital | — |
| Recruiting | PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma. NCT07053072 | West China Hospital | Phase 1 / Phase 2 |
| Enrolling By Invitation | The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Li NCT07537205 | Fudan University | N/A |
| Recruiting | An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Th NCT07315633 | University Hospital, Ghent | — |
| Not Yet Recruiting | 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) NCT06852820 | Melissa Lumish | Phase 2 |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | Y-90 Treatment Response Using Transarterial Radioembolization NCT07145801 | Thomas Jefferson University | Phase 2 |
| Not Yet Recruiting | AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy NCT07118735 | National Cheng-Kung University Hospital | N/A |
| Not Yet Recruiting | Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on NCT07056270 | Tongji Hospital | — |
| Recruiting | Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of NCT06753136 | Istituto Oncologico Veneto IRCCS | N/A |
| Recruiting | Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051 | Natera, Inc. | — |
| Recruiting | HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receivin NCT06899152 | Montefiore Medical Center | N/A |
| Active Not Recruiting | A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors NCT07362264 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 |
| Recruiting | Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis NCT07044362 | Case Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Proteomic Analysis of Patients Undergoing Bariatric Surgery NCT06787807 | Universidade Federal de Pernambuco | N/A |
| Recruiting | CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection NCT07053488 | AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | Phase 1 / Phase 2 |
| Not Yet Recruiting | The Application Value of Spectral CT in the Accurate Staging of Liver Cancer NCT06977399 | Yunnan Cancer Hospital | N/A |
| Completed | Effects of Different Anesthetic Techniques on Intraoperative and Postoperative Pain Levels and Cognitive Funct NCT07097220 | Sir Run Run Shaw Hospital, Qingchun Campus, Zhejiang University School of Medicine, | N/A |
| Recruiting | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 1 |
| Recruiting | Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention NCT07010315 | M.D. Anderson Cancer Center | — |
| Not Yet Recruiting | In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients NCT06827639 | Assistance Publique Hopitaux De Marseille | — |
| Recruiting | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies NCT07327489 | Elephas | — |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Recruiting | Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma NCT06950814 | West China Hospital | — |
| Recruiting | Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329 | Brian Henick, MD | Phase 1 |
| Not Yet Recruiting | ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population NCT06790355 | Shanghai Weihe Medical Laboratory Co., Ltd. | N/A |
| Recruiting | SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastat NCT06873659 | Qurgen Inc. | Phase 1 |
| Recruiting | Feasibility Study of CBCT for IGRT in Cancer Patients NCT06681233 | Varian, a Siemens Healthineers Company | N/A |
| Not Yet Recruiting | FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation NCT06409637 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1 / Phase 2 |
| Recruiting | TACE Combined Surgery for the Resectable Huge HCC NCT06898398 | Sun Yat-sen University | — |
| Recruiting | China Liver Cancer Clinical Registry Cohort Database (HEAL) NCT06777485 | Anhui Provincial Hospital | — |
| Recruiting | Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663 | RenJi Hospital | Phase 2 / Phase 3 |
| Recruiting | Target-specific immunoPET Imaging of Digestive System Carcinoma NCT06715839 | RenJi Hospital | N/A |
| Recruiting | Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial NCT06580002 | University of California, Irvine | Phase 2 |
| Not Yet Recruiting | A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC NCT06584071 | Biotheus Inc. | Phase 1 / Phase 2 |
| Recruiting | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With NCT06263088 | Case Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patien NCT06632522 | Beijing Tsinghua Chang Gung Hospital | Phase 2 |
| Recruiting | DEB-TACE Prior to Liver Transplantation in the Treatment of HCC NCT06353126 | RenJi Hospital | Phase 4 |
| Recruiting | AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886 | Guo ShiWei | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | HAIC Compared With TACE in Huge Hepatocellular Carcinoma NCT06641713 | Sun Yat-sen University | — |
| Recruiting | Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial NCT05744219 | Jon Unosson | Phase 3 |
| Not Yet Recruiting | Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs) NCT06563934 | Xu Yong, MD | Phase 2 |
| Not Yet Recruiting | a Cohort Study (Gut Microbiota and HCC) NCT06557213 | Xu Yong, MD | — |
| Recruiting | TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery NCT06050200 | Medical University of Warsaw | N/A |
| Not Yet Recruiting | Single Arm Clinical Trial (Gut Microbiota and HCC) NCT06563947 | Xu Yong, MD | Phase 2 |
| Recruiting | Early Detection of Liver Cancer by QUS NCT06345508 | Centre hospitalier de l'Université de Montréal (CHUM) | — |
| Recruiting | Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Ra NCT06536998 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Recruiting | Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arte NCT07356531 | JIANGSU SHENMING Medical Technology CO., Ltd | N/A |
| Recruiting | A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Soli NCT06440005 | Angiex, Inc. | Phase 1 |
| Recruiting | INSPIRE: a Multi-Cancer Early Detection Study NCT06440018 | Singlera Genomics Inc. | — |
| Recruiting | Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS NCT06590948 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Active Not Recruiting | Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 NCT06384417 | Milton S. Hershey Medical Center | N/A |
| Recruiting | Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT NCT06482801 | Second Affiliated Hospital of Guangzhou Medical University | Phase 2 |
| Recruiting | Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatri NCT04715191 | Baylor College of Medicine | Phase 1 |
| Not Yet Recruiting | Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer NCT06408623 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | GPC3/Mesothelin-CAR-γδT Cells Against Cancers NCT06196294 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 |
| Recruiting | Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy NCT06341270 | West China Hospital | N/A |
| Not Yet Recruiting | A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer NCT06356623 | Shanghai Zhongshan Hospital | — |
| Recruiting | Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy NCT06406244 | West China Hospital | N/A |
| Not Yet Recruiting | A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery NCT06369597 | Sun Yat-sen University | N/A |
| Recruiting | Interventional Software for Multi-immunotherapy of Solid Tumors NCT06478108 | Second Affiliated Hospital of Guangzhou Medical University | Phase 2 / Phase 3 |
| Unknown | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis NCT06363123 | Beijing Friendship Hospital | — |
| Recruiting | Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic NCT06227728 | Gene Solutions | — |
| Active Not Recruiting | A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Ad NCT06091930 | Boehringer Ingelheim | Phase 1 |
| Recruiting | PRIORITY-CONNECT 2 Pilot Trial NCT06212700 | Surgical Outcomes Research Centre (SOuRCe) | N/A |
| Recruiting | A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Car NCT06326502 | Etnova Therapeutics Corp. | Phase 1 |
| Recruiting | The AMARA (As Much As Reasonably Achievable) Study NCT06257030 | University Hospital of Patras | — |
| Not Yet Recruiting | Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma NCT06175845 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Not Yet Recruiting | Liver Transplantation After ex Vivo Liver Perfusion NCT05951231 | Oslo University Hospital | N/A |
| Unknown | Quantitative MRI and Outcomes of Liver Resection NCT06181318 | University Hospital Heidelberg | — |
| Recruiting | Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC NCT06251115 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Recruiting | Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors NCT06179602 | Leiden University Medical Center | — |
| Not Yet Recruiting | Effects of CBT-Based Intervention Among Patients With Liver Cancer NCT05942560 | The Nethersole School of Nursing | N/A |
| Recruiting | National Liver Cancer Screening Trial NCT06084234 | University of Texas Southwestern Medical Center | Phase 4 |
| Completed | Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone NCT06173466 | Zhejiang Cancer Hospital | Phase 4 |
| Active Not Recruiting | First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vacci NCT05964361 | University Hospital, Antwerp | Phase 1 / Phase 2 |
| Unknown | Evaluation of the Ablation of Hepatic Lesions by Electroporation NCT06289712 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients NCT05850130 | GERCOR - Multidisciplinary Oncology Cooperative Group | N/A |
| Completed | Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy NCT06130436 | The Second Affiliated Hospital of Chongqing Medical University | N/A |
| Recruiting | Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers NCT06139042 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Recruiting | Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? NCT05492136 | Hospital del Mar | N/A |
| Completed | Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation NCT06003218 | Peking University First Hospital | N/A |
| Active Not Recruiting | Detect and Expunge Concealed Tumors of the Liver NCT06141564 | Johns Hopkins University | — |
| Unknown | The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy NCT06342323 | Peking University Third Hospital | — |
| Active Not Recruiting | Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) T NCT07207343 | National Taiwan University Hospital | N/A |
| Active Not Recruiting | The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers NCT07214363 | National Taiwan University Hospital | N/A |
| Active Not Recruiting | Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) NCT05953337 | ABK Biomedical | N/A |
| Unknown | 3D Printed Models for Liver Surgery NCT06006338 | Zhejiang Cancer Hospital | Phase 1 |
| Active Not Recruiting | Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma NCT05622136 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Recruiting | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing NCT06036563 | Air Force Military Medical University, China | — |
| Withdrawn | Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment NCT05510427 | M.D. Anderson Cancer Center | Phase 1 |
| Unknown | Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation NCT06178926 | Zhejiang Cancer Hospital | N/A |
| Unknown | Primary Liver Cancer Early Detection NCT05996666 | The First Hospital of Jilin University | — |
| Unknown | Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC NCT05718882 | RenJi Hospital | N/A |
| Recruiting | Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform NCT05520099 | Elephas | — |
| Recruiting | PDO/PDO-TIL/PDOTS for Drug Screen NCT05913141 | Shanghai Zhongshan Hospital | — |
| Active Not Recruiting | Domvanalimab and Zimberelimab in Advanced Liver Cancers NCT05724563 | University of Texas Southwestern Medical Center | Phase 2 |
| Unknown | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 NCT05829057 | Zhejiang University | Phase 1 |
| Recruiting | The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action NCT05926336 | Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 4 |
| Enrolling By Invitation | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenviron NCT05600933 | National Cancer Institute (NCI) | — |
| Unknown | HOPE to Reduce Tumour Recurrence After LT In Patients With HCC NCT05876052 | University of Bologna | N/A |
| Recruiting | TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma NCT06114082 | Seoul National University Hospital | Phase 2 |
| Withdrawn | GI Organ Tracking Via Balloon Applicators NCT05471401 | Washington University School of Medicine | N/A |
| Recruiting | Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials NCT05146297 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) NCT05723705 | Amsterdam UMC, location VUmc | — |
| Unknown | Cross-sectional Study of Chinese Liver Cancer Patients NCT05872828 | The Nethersole School of Nursing | — |
| Unknown | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid T NCT05886075 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Unknown | A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection NCT05781581 | RenJi Hospital | — |
| Terminated | Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C NCT05717400 | M.D. Anderson Cancer Center | Phase 4 |
| Active Not Recruiting | TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribut NCT05743842 | M.D. Anderson Cancer Center | N/A |
| Unknown | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors NCT05860374 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Recruiting | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology NCT05184790 | University of Sydney | — |
| Unknown | A Prospective, Single-arm, Multicenter Clinical Trial of Safety and Effectiveness of EUS-LA for Liver Cancer NCT05709886 | First Affiliated Hospital of Zhejiang University | N/A |
| Withdrawn | A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhib NCT05039736 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC NCT05727787 | University of Kansas Medical Center | N/A |
| Unknown | Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma NCT05738447 | West China Hospital | Phase 1 |
| Unknown | Main Postoperative Complications After COVID-19 NCT05694949 | RenJi Hospital | — |
| Active Not Recruiting | The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Bio NCT07233759 | National Taiwan University Hospital | — |
| Completed | Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy NCT05176860 | Varian, a Siemens Healthineers Company | N/A |
| Completed | I-FIGS Feasibility Study NCT05616039 | University Hospital Plymouth NHS Trust | N/A |
| Recruiting | FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. NCT05095714 | Assistance Publique - Hôpitaux de Paris | N/A |
| Unknown | A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer NCT05719480 | Nanfang Hospital, Southern Medical University | — |
| Completed | HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC NCT05532319 | Guangxi Medical University | Phase 2 |
| Unknown | Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure NCT05360420 | Tianjin Third Central Hospital | N/A |
| Recruiting | Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Inv NCT05992220 | Asan Medical Center | Phase 2 |
| Terminated | A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types K NCT05497453 | Omega Therapeutics | Phase 1 / Phase 2 |
| Recruiting | ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma NCT04634357 | Eureka Therapeutics Inc. | Phase 1 / Phase 2 |
| Completed | Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT NCT05183776 | Radboud University Medical Center | N/A |
| Completed | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients NCT05638048 | Junyan Zhao | N/A |
| Unknown | Project CADENCE (CAncer Detected Early caN be CurEd) NCT05633342 | MiRXES Pte Ltd | — |
| Unknown | VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY NCT05369988 | Hospital Miguel Servet | — |
| Recruiting | Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma NCT05444478 | Sun Yat-sen University | N/A |
| Recruiting | Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection NCT05517811 | University of Colorado, Denver | — |
| Terminated | Utilization of MAsS in Patients Undergoing LT for HCC NCT05184283 | Columbia University | — |
| Unknown | [18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity NCT05806333 | Jilin University | N/A |
| Completed | Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compar NCT05430841 | The First Affiliated Hospital of Xiamen University | N/A |
| Unknown | Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment NCT05443230 | First Affiliated Hospital of Wenzhou Medical University | — |
| Unknown | Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments NCT05443217 | First Affiliated Hospital of Wenzhou Medical University | — |
| Completed | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients NCT05411133 | Arbele Pty Ltd | Phase 1 |
| Unknown | IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation NCT05339581 | RenJi Hospital | N/A |
| Unknown | Fluorescent-labeled IgG for Liver Tumor Detection NCT05394246 | Chinese Academy of Sciences | N/A |
| Withdrawn | Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With NCT04931420 | University of Chicago | Phase 2 |
| Unknown | Liver Transplantation for Unresectable GIST Liver Metastases NCT04825470 | Hospital Universitario Virgen de la Arrixaca | N/A |
| Completed | Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) NCT05044065 | Karolinska Institutet | N/A |
| Unknown | Displacement Distance and Stabilization Time for Liver Fiducial Marker NCT05816837 | Peking University Third Hospital | — |
| Terminated | A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours NCT05363605 | Fusion Pharmaceuticals Inc. | Phase 1 / Phase 2 |
| Terminated | International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy NCT05342350 | Johns Hopkins University | — |
| Unknown | Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy NCT05322187 | RenJi Hospital | Phase 2 / Phase 3 |
| Completed | Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancie NCT05462314 | Viome | — |
| Unknown | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver NCT05192460 | jianming xu | N/A |
| Completed | Nutrition and Exercise Prehabilitation to Reduce Morbidity Following Major Liver Surgery in Sarcopenic Patient NCT05281211 | San Camillo Hospital, Rome | N/A |
| Recruiting | Multi-analyte Blood Test Clinical Trial NCT05199259 | Helio Genomics | — |
| Unknown | A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. NCT05598268 | ImmVira Pharma Co. Ltd | Phase 1 / Phase 2 |
| Recruiting | A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China NCT05638269 | Zhujiang Hospital | — |
| Active Not Recruiting | Pressure-enabled Delivery in Radioembolization (TriNav Study) NCT05128032 | Massachusetts General Hospital | N/A |
| Unknown | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer NCT03958019 | University of Dublin, Trinity College | N/A |
| Completed | Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer NCT05540925 | Eastern Hepatobiliary Surgery Hospital | — |
| Withdrawn | LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery NCT04105062 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Unknown | Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Pati NCT05343832 | Genetron Health | — |
| Completed | Registry to Collect Health Information Related to Fibrolamellar Cancer NCT04874519 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures NCT04769713 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 |
| Unknown | Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer NCT05032014 | Jiangxi Provincial Cancer Hospital | N/A |
| Completed | Perioperative Intravenous Lidocaine in Liver Surgery NCT05153785 | Lund University Hospital | Phase 2 / Phase 3 |
| Completed | Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC NCT04926376 | ABK Biomedical | N/A |
| Recruiting | Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors NCT05187338 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 / Phase 2 |
| Recruiting | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643 | Cedars-Sinai Medical Center | N/A |
| Unknown | Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver C NCT05160740 | Zhujiang Hospital | N/A |
| Unknown | Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors NCT05123209 | Beijing Immunochina Medical Science & Technology Co., Ltd. | Phase 1 |
| Active Not Recruiting | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid NCT04377932 | Baylor College of Medicine | Phase 1 |
| Active Not Recruiting | National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer NCT04145141 | National Cancer Institute (NCI) | — |
| Active Not Recruiting | ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk NCT05064553 | Exact Sciences Corporation | — |
| Completed | Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure NCT06013774 | UMC Utrecht | N/A |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Terminated | Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) NCT04502082 | Eureka Therapeutics Inc. | Phase 1 |
| Completed | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) NCT04825834 | Delfi Diagnostics Inc. | — |
| Recruiting | Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT NCT04843176 | The University of Hong Kong | N/A |
| Active Not Recruiting | Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing NCT04597710 | Perspectum | — |
| Recruiting | Pre- Vs Postoperative Thromboprophylaxis for Liver Resection NCT04731558 | Helsinki University Central Hospital | Phase 4 |
| Active Not Recruiting | Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer NCT05931445 | Comprehensive Support Project for Oncology Research | N/A |
| Recruiting | "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors NCT04690972 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Completed | Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection NCT02649153 | Guangxi Medical University | Phase 3 |
| Recruiting | Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors NCT04842812 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 |
| Completed | Liver CT Dose Reduction With Deep Learning Based Reconstruction NCT05804799 | Seoul National University Hospital | — |
| Withdrawn | Hepatic Artery Infusion (HAI) Program at Duke University NCT04511793 | Michael Lidsky, M.D. | N/A |
| Completed | Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation NCT04618692 | Istanbul Medipol University Hospital | N/A |
| Completed | Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes NCT05475054 | Fondazione Poliambulanza Istituto Ospedaliero | — |
| Unknown | Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Study of Different Outcomes and NCT04739501 | Assiut University | — |
| Unknown | Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers NCT04682847 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | — |
| Unknown | Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC NCT04653701 | Juan José Ciampi Dopazo | — |
| Recruiting | Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veter NCT04933435 | Duke University | N/A |
| Recruiting | 4D-MRI for Precision Medicine NCT04657042 | University of Virginia | — |
| Recruiting | Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma NCT04134559 | Allison O'Neill, MD | Phase 2 |
| Recruiting | Jump: MR Simulation For Radiation Therapy Master Protocol NCT04545957 | Brigham and Women's Hospital | N/A |
| Unknown | Hepatobiliary Tumors Tissue Samples Acquisition NCT04445532 | Peking Union Medical College Hospital | — |
| Unknown | Viscoelasticity Imaging to Assess Liver Cancer NCT04409340 | Centre hospitalier de l'Université de Montréal (CHUM) | — |
| Recruiting | (3D) Ultrasound Imaging Liver and Kidney NCT03844399 | Western University, Canada | — |
| Recruiting | Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy NCT07186010 | Asan Medical Center | — |
| Terminated | Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Asses NCT04589884 | IHU Strasbourg | — |
| Recruiting | Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS NCT04868149 | The University of Hong Kong | Phase 3 |
| Unknown | HR Versus RFA for Early Stage HCC NCT02169765 | Guangxi Medical University | Phase 3 |
| Completed | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S NCT04430842 | Quadriga Biosciences, Inc. | Phase 1 |
| Completed | Neoadjuvant Anti-PD1 in HCC NCT05471674 | Dr Tan-to CHEUNG | Phase 2 |
| Completed | Nutrition in Gastrointestinal Tumors NCT04476082 | University Medicine Greifswald | — |
| Completed | Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma NCT04576572 | Inonu University | — |
| Completed | Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients NCT05989789 | Clarunis - Universitäres Bauchzentrum Basel | N/A |
| Recruiting | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer NCT06084299 | Zhiyong Huang | Phase 1 |
| Completed | Radiofrequency-assisted Liver Resection in Intractable Liver Cancer NCT04413526 | Hepatopancreatobiliary Surgery Institute of Gansu Province | — |
| Unknown | Relationship Between Liver Cancer and Sarcopenia NCT05339919 | First Affiliated Hospital of Wenzhou Medical University | — |
| Unknown | Genomics and Prognosis in GI Cancers NCT05767697 | National Health Research Institutes, Taiwan | — |
| Unknown | A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver C NCT04309747 | First Affiliated Hospital of Zhejiang University | N/A |
| Unknown | Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer NCT04348643 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Terminated | Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE NCT04150874 | H. Lee Moffitt Cancer Center and Research Institute | EARLY_Phase 1 |
| Completed | Liver Cancer Community Education NCT04272619 | Fox Chase Cancer Center | N/A |
| Terminated | NOLA (NeuWave Observational Liver Ablation) Registry NCT04107766 | Ethicon, Inc. | — |
| Completed | Deep Learning Model for the Prediction of Post-LT HCC Recurrence NCT05200195 | European Hepatocellular Cancer Liver Transplant Group | — |
| Active Not Recruiting | Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) NCT02984566 | University of Sydney | N/A |
| Unknown | ARAPS Study on Accelerated Liver Regeneration NCT04107324 | University of Aarhus | N/A |
| Recruiting | Effect and Mechanism of ALPPS Operation on Liver Regeneration NCT07142213 | Haitao Zhao, MD | — |
| Unknown | GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer NCT04206254 | Cure&Sure Biotech Co., LTD | Phase 2 / Phase 3 |
| Completed | Real-time Imaging of Holmium Radioembolization: a Feasibility Study NCT04269499 | Radboud University Medical Center | N/A |
| Terminated | Ablation Confirmation Study NCT03753789 | Ethicon, Inc. | N/A |
| Completed | Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy NCT04707547 | Taipei Medical University WanFang Hospital | Phase 4 |
| Unknown | Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy NCT04215861 | The First Affiliated Hospital of Dalian Medical University | — |
| Completed | Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo Trial NCT04106453 | Universitätsklinikum Köln | N/A |
| Completed | Breath Analysis Based Disease Biomarkers NCT04341012 | Mayo Clinic | — |
| Not Yet Recruiting | Hepatocarcinoma Recurrence on the Liver Study - Part2 NCT04053231 | University of Milano Bicocca | — |
| Recruiting | PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies NCT04371042 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients NCT03891654 | University of Colorado, Denver | EARLY_Phase 1 |
| Unknown | To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients NCT05369650 | West China Hospital | N/A |
| Unknown | A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain NCT04014478 | Shanghai Golden Leaf MedTec Co. Ltd | N/A |
| Unknown | Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging NCT04705194 | University of Leeds | — |
| Not Yet Recruiting | Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation NCT03946852 | London Health Sciences Centre | N/A |
| Unknown | ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer NCT03965546 | First Affiliated Hospital Xi'an Jiaotong University | EARLY_Phase 1 |
| Terminated | Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma NCT03998033 | Eureka Therapeutics Inc. | Phase 1 |
| Active Not Recruiting | DIAbetes and NAFLD NCT06315361 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Active Not Recruiting | Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer NCT03408665 | Centre Oscar Lambret | N/A |
| Completed | The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver Resection NCT03813953 | University of Edinburgh | N/A |
| Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study NCT04075305 | UMC Utrecht | — |
| Unknown | Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer NCT03843229 | The First Affiliated Hospital of Dalian Medical University | Phase 4 |
| Completed | Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection NCT02654028 | Guangxi Medical University | N/A |
| Recruiting | Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma NCT03949231 | Second Affiliated Hospital of Guangzhou Medical University | Phase 3 |
| Active Not Recruiting | Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (G NCT02932956 | Baylor College of Medicine | Phase 1 |
| Completed | HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) NCT03804593 | Epigenomics, Inc | — |
| Completed | PAN-study: Pan-Cancer Early Detection Study (PAN) NCT03756597 | Owlstone Ltd | — |
| Enrolling By Invitation | Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy NCT04466124 | National Cancer Center, Korea | — |
| Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors NCT03662204 | Exact Sciences Corporation | — |
| Unknown | Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver Resection NCT03620916 | Medical University of Warsaw | N/A |
| Active Not Recruiting | QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope NCT03552718 | NantBioScience, Inc. | Phase 1 |
| Unknown | Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) NCT03739164 | Florida Hospital Tampa Bay Division | — |
| Completed | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Ge NCT03602079 | Klus Pharma Inc. | Phase 1 / Phase 2 |
| Unknown | The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients NCT03223818 | Chinese University of Hong Kong | N/A |
| Unknown | Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos NCT03668418 | University of Pisa | — |
| Completed | Personal Resilience Empowerment Program Study NCT03644173 | Hackensack Meridian Health | N/A |
| Recruiting | Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac NCT04172753 | University Hospital Tuebingen | N/A |
| Unknown | Accuracy of the LiverVision® Semi-automated Liver Volumetry Software NCT03766633 | Royal Free Hospital NHS Foundation Trust | — |
| Completed | Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) NCT04288323 | University of California, San Diego | Phase 4 |
| Completed | Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study NCT03405909 | University Hospital Erlangen | — |
| Active Not Recruiting | A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Cu NCT03383458 | Bristol-Myers Squibb | Phase 3 |
| Completed | The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients NCT03723304 | European Hepatocellular Cancer Liver Transplant Group | — |
| Recruiting | Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms NCT03981497 | Francesco De Cobelli | — |
| Terminated | RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry NCT03516695 | Boston Scientific Corporation | — |
| Completed | Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC NCT03784469 | National Taiwan University Hospital | N/A |
| Completed | Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma NCT07204262 | Xu Yong, MD | — |
| Completed | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory NCT03199586 | Novita Pharmaceuticals, Inc. | Phase 1 |
| Completed | ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma NCT03888859 | First Affiliated Hospital Xi'an Jiaotong University | EARLY_Phase 1 |
| Unknown | Standard of Care Versus Hemopatch® During Liver Resection NCT03166683 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | N/A |
| Terminated | High Dose Rate Brachyablation of Primary Liver Lesions NCT02893982 | University of Texas Southwestern Medical Center | Phase 1 |
| Terminated | Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma NCT03349255 | Aeon Therapeutics (Shanghai) Co., Ltd. | Phase 1 |
| Unknown | Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC NCT04221347 | Military University Hospital, Prague | — |
| Unknown | Nursing Fro Laparoscopic vs. Open Hepatectomy NCT03585166 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Terminated | Liver Regeneration NCT03396705 | University Health Network, Toronto | — |
| Completed | HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies NCT03213314 | University of Edinburgh | N/A |
| Terminated | A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver NCT02966223 | Indiana University | N/A |
| Completed | CIRSE Registry for SIR-Spheres in France (CIRT-FR) NCT03256994 | Cardiovascular and Interventional Radiological Society of Europe | — |
| Unknown | Volatiles in Breath and Headspace Analysis - Diagnostic Markers NCT03228095 | University of Latvia | — |
| Completed | Value of 3D Printing for Comprehension of Liver Surgical Anatomy NCT03153332 | Guangzhou Women and Children's Medical Center | — |
| Completed | Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton Therapies NCT03226925 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Completed | Safety and Efficiency of γδ T Cell Against Liver Cancer NCT03183219 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Completed | Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in NCT03111732 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy NCT03338062 | Indiana University | N/A |
| Unknown | Celebrex and Metformin for Postoperative Hepatocellular Carcinoma NCT03184493 | Guangxi Medical University | Phase 3 |
| Completed | The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequ NCT05732181 | National Cheng-Kung University Hospital | N/A |
| Active Not Recruiting | A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization NCT03143270 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Unknown | Application of 3D Printing in Laparoscopic Surgery of Liver Tumors NCT03744624 | Jagiellonian University | N/A |
| Withdrawn | Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma NCT02989870 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Completed | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular NCT03164382 | Sun Yat-sen University | Phase 3 |
| Unknown | Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program NCT03475966 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Completed | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 NCT03058289 | Intensity Therapeutics, Inc. | Phase 1 / Phase 2 |